Case Details
- Citation: [2013] SGHC 2
- Case Title: Biomedia Pharma Pte Ltd (formerly known as Malaysia Chemist Pte Ltd) v TAC Distribution Pte Ltd (trading as Trane Singapore) (Amcrotech Pte Ltd, third party)
- Court: High Court of the Republic of Singapore
- Date of Decision: 10 January 2013
- Judge: Choo Han Teck J
- Procedural Context: Assessment of damages following liability judgment
- Case Number: Suit No 143 of 2009 (assessment of damages)
- Coram: Choo Han Teck J
- Plaintiff/Applicant: Biomedia Pharma Pte Ltd (formerly known as Malaysia Chemist Pte Ltd)
- Defendant/Respondent: TAC Distribution Pte Ltd (trading as Trane Singapore) (Amcrotech Pte Ltd, third party)
- Third Party: Amcrotech Pte Ltd
- Legal Area: Contract — Remedies (Damages)
- Statutes Referenced: None stated in the provided judgment extract
- Counsel for Plaintiff: Mansurhusain Akbar Hussein (Jacob Mansur & Pillai)
- Counsel for Defendant: Niru Pillai (Global Law Alliance LLC)
- Counsel for Third Party: Michael Chia Peng Chuang (Pereira & Tan LLC)
- Prior Liability Judgment Date: 8 November 2010 (judgment in favour of plaintiff; damages ordered to be assessed)
- Hearing Dates for Quantum: July 2012 (assessment heard); verdict on quantum given on 24 September 2012
- Judgment Length: 2 pages; 549 words (as indicated in metadata)
Summary
This High Court decision concerns the assessment of damages arising from a prior liability judgment for breach of contract. In the earlier judgment dated 8 November 2010, the court found that TAC Distribution Pte Ltd (trading as Trane Singapore) had breached its contractual obligation to design and install a specialised air-conditioning system for Biomedia Pharma Pte Ltd’s factory premises. The damages were ordered to be assessed, and the present decision addresses the quantum.
The court ultimately awarded Biomedia a total of $185,000. This comprised $135,000 as reimbursement of the sum paid by Biomedia to TAC Distribution, together with $50,000 in general damages. The defendant argued that the plaintiff should not recover both a refund (reimbursement) and general damages for breach. The court accepted that some heads of claim were not properly pleaded and therefore could not be awarded, but it held that the proven payment of $135,000 was a distinct element of loss and that there remained a further general, non-precisely quantifiable component—such as inconvenience and trouble—arising from the breach.
What Were the Facts of This Case?
Biomedia Pharma Pte Ltd leased a factory building to carry on its pharmaceutical business. The business required the premises to function as a “dry laboratory”. For that purpose, Biomedia engaged TAC Distribution Pte Ltd, a specialist in air-conditioning systems, to design and install a specialised air-conditioning system for the factory. The contractual arrangement was therefore not merely about providing general cooling; it was directed at achieving a specific environmental outcome necessary for Biomedia’s regulated laboratory use.
Although TAC Distribution was the contracting party responsible for the design and installation, the actual installation work was carried out by a third party, Amcrotech Pte Ltd. This structure matters because it frames the breach as a failure to deliver a system that complied with the contract, even if the physical installation was performed by another entity. In the earlier liability judgment, the defendant’s counterclaim and third party action were dismissed, leaving the defendant responsible for the breach found by the court.
After installation, the system did not meet the contractual requirements. The breach had regulatory consequences: the Health Sciences Authority withheld the grant of a licence that would have allowed Biomedia to use the factory as a dry laboratory. The withholding of the licence meant that Biomedia could not proceed with the intended use of the premises, and the breach contributed—though not necessarily exclusively—to the closure of Biomedia’s business.
Following the liability judgment, the court proceeded to assess damages. The assessment was heard in July 2012, and the court delivered its verdict on quantum on 24 September 2012. The present decision records the reasoning for the damages awarded, particularly in response to the defendant’s argument that the plaintiff should not receive both reimbursement of the contract payment and general damages for breach.
What Were the Key Legal Issues?
The central issue was the proper measure and composition of damages for breach of contract in the context of both (i) a proven payment made under the contract and (ii) additional losses that were not capable of precise quantification. Specifically, the court had to decide whether Biomedia could recover the $135,000 it paid to TAC Distribution and, in addition, claim general damages for the breach.
A related issue concerned pleading and proof. The defendant’s position, as reflected in the court’s reasoning, included an argument that certain damages should not be awarded because they were not properly pleaded. The court had to determine which heads of loss were properly before it and which were not. This is a recurring procedural and substantive concern in damages assessments: the court cannot award damages for claims that were not pleaded, even if they might be factually arguable.
Finally, the court had to address causation and attribution. While the breach resulted in the Health Sciences Authority withholding the licence, the court also recognised that it did not assume the plaintiff’s business loss could be wholly attributed to the defendant’s breach. The issue, therefore, was how to value the general, business-related consequences of the breach when causation is probabilistic rather than exclusive.
How Did the Court Analyse the Issues?
Choo Han Teck J began by placing the assessment within the framework established by the earlier liability judgment. The court had already found breach of contract and ordered damages to be assessed. In the quantum assessment, the judge agreed with the defendant in the “main” and awarded $135,000 as reimbursement of the sum paid by Biomedia to TAC Distribution. The payment itself was not disputed, and the court treated the failure to hand over a system that complied with the contract as the basis for reimbursement.
The defendant’s key argument was that Biomedia should not be awarded both the refund (reimbursement) and general damages. In other words, TAC Distribution contended that awarding reimbursement for the contract sum would overlap with, and therefore preclude, any additional general damages for breach. The court’s approach was to separate the proven element of loss from the general, non-precisely assessable element.
On the pleading point, the court accepted the defendant’s argument only to the extent that other claims were concerned. The judge held that certain special damages could not be awarded because they had not been pleaded. This reflects a strict adherence to procedural fairness: damages must be pleaded with sufficient specificity so that the defendant knows the case it has to meet. Even where evidence might exist, the court will not award damages for unpleaded heads of loss.
However, the judge distinguished the reimbursement of $135,000 from the general damages component. The $135,000 was a “damages” element that was clearly proved: it represented the payment made by Biomedia to TAC Distribution. The court therefore treated reimbursement as a legitimate and distinct component of the damages award. The judge then identified a further element of loss—general damage—arising from the breach, which could not be precisely assessed. This general damage was linked to the inconvenience and trouble suffered by Biomedia due to the breach.
In valuing the general damages, the court adopted a pragmatic method. It acknowledged that the breach had a probable contribution to the closure of Biomedia’s business, but it did not assume that the business closure was wholly caused by the defendant’s breach. This is an important nuance in damages assessment: where multiple factors may contribute to a loss, the court must avoid attributing the entire loss to the breach unless causation is established on the appropriate standard.
The judge then explained that valuing the general, business-related consequences requires the court to consider multiple factors: the nature of the business, the consequence of the breach, the nature and size of the contract, and the nature of the breach. These factors guide the court in determining a fair and reasonable sum that reflects the impact of the breach without overcompensating the claimant. The court’s reasoning indicates that general damages in this context are not purely punitive; they are compensatory and grounded in the practical realities of the contractual failure.
Applying these considerations, the court added another $50,000 to the plaintiff’s claim, resulting in a total award of $185,000. The structure of the award demonstrates the court’s balancing exercise: reimbursement for the proven payment, plus a separate general damages component for the non-quantifiable consequences of the breach.
What Was the Outcome?
The court awarded Biomedia Pharma a total of $185,000 in damages. This comprised $135,000 as reimbursement of the amount paid by Biomedia to TAC Distribution, and $50,000 as general damages for the inconvenience and trouble suffered due to the breach of contract.
In practical terms, the decision confirms that a claimant may recover both reimbursement of a proven payment and general damages, provided the general damages represent a distinct compensable loss that is not fully captured by the reimbursement. It also underscores that special damages must be properly pleaded; otherwise, they will not be awarded even if the factual background might suggest they are arguable.
Why Does This Case Matter?
This case is useful for practitioners because it illustrates how Singapore courts approach damages assessment where there is both a proven monetary outlay and additional non-quantifiable consequences of contractual breach. The decision provides a clear example of the court’s willingness to award reimbursement for a contract payment while still granting general damages for the broader impact of the breach.
From a remedies perspective, the case reinforces two practical principles. First, pleading discipline matters: special damages that are not pleaded cannot be recovered. Second, general damages may still be awarded even where a refund or reimbursement is granted, so long as the general damages correspond to a separate element of loss that cannot be precisely measured. This is particularly relevant in construction- and systems-installation disputes, where contractual non-compliance can trigger regulatory consequences, operational disruption, and consequential inconvenience.
For lawyers advising clients, the decision also highlights the importance of causation framing. The court did not assume that the claimant’s business closure was wholly attributable to the breach. Instead, it treated the breach as a probable contribution and then valued the general loss accordingly. This approach is instructive for litigants seeking damages for business-related consequences: courts may require a careful articulation of how the breach contributed to the loss and a reasoned basis for quantification that does not overreach beyond what causation supports.
Legislation Referenced
- None stated in the provided judgment extract.
Cases Cited
- [2013] SGHC 2 (the decision itself; no other cited cases are stated in the provided extract).
Source Documents
This article analyses [2013] SGHC 2 for legal research and educational purposes. It does not constitute legal advice. Readers should consult the full judgment for the Court's complete reasoning.